This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>Kenan m fix broken data |
>Tracer Grammatics |
||
| Line 45: | Line 45: | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Dissociative]] | |EffectClass=[[psychoactive class::Dissociative]] | ||
|ChemicalClass=[[Arylcyclohexylamine]] | |ChemicalClass=[[chemical class::Arylcyclohexylamine]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
| Line 53: | Line 53: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::1]] | |OralROA_Threshold=[[Oral threshold dose::1]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::5]] mg | |OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::5]] mg | ||
|OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | ||
| Line 70: | Line 70: | ||
|InsufflatedROA_Caption= | |InsufflatedROA_Caption= | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::2]] | |InsufflatedROA_Threshold=[[Insufflated threshold dose::2]] [[Insufflated dose units::mg]] | ||
|InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | |InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
Revision as of 14:08, 25 December 2019
| SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||
| Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||
| Systematic name | 2-(Ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
| Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||